Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Ekterly (sebetralstat) the First and Only Oral On-demand Treatment for Hereditary Angioedema (HAE)

CAMBRIDGE, Mass. & SALISBURY, England, July 7, 2025 (BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food...

FDA Grants Accelerated Approval to Lynozyfic (linvoseltamab-gcpt) for Treatment of Relapsed or Refractory Multiple Myeloma

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Lynozyfic...

FDA Grants Accelerated Approval to Zegfrovy (sunvozertinib) for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

July 2, 2025 – Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological...

EMS Calls to Schools Usually Result in Hospital Transport

Most emergency medical service (EMS) responses to schools result in transport to the hospital setting, according to a study published online July 1 in Pediatrics.Michael...

Uterine Cancer Incidence, Mortality Expected to Increase Through 2050

Uterine cancer incidence and mortality rates are projected to increase significantly through 2050, according to a study published online July 1 in Cancer...

Delirium Common Among Critically Ill Patients With Stroke

More than one in four critically ill patients with stroke experience delirium, according to a study published online July 1 in the American Journal...

Updated Recommendations Issued for Management of Grade 4 Diffuse Glioma

In a clinical practice guideline issued by the American Society for Radiation Oncology and published online June 25 in Practical Radiation Oncology, updated...

These Items Sold at Costco Have Been Recalled — Check Your Home

TUESDAY, July 8, 2025 — If you shop at Costco, you may want to check your home for items that have recently been recalled.In the past few months, the...

U.S. Measles Cases Hit Highest Level Since Disease Was Eliminated in 2000

TUESDAY, July 8, 2025 — Measles cases in the United States have reached their highest level in 25 years, with more than 1,270 confirmed cases this year.That...

Kids’ Health in U.S. Has Gotten Worse Over the Past 17 Years, Study Finds

TUESDAY, July 8, 2025 — The health of American kids has worsened over the past 17 years, with more now struggling with obesity, mental health problems...

Common Meds Aren't Linked To Inflammatory Bowel Disease, Study Says

TUESDAY, July 8, 2025 — There’s no evidence that common medications can trigger a chronic inflammatory bowel disease called microscopic colitis, a...

Apogee Therapeutics Announces Positive 16-Week Data from Phase 2 APEX Clinical Trial of APG777, its Potentially Best-in-Class Anti-IL-13 Antibody, in Moderate-to-Severe Atopic Dermatitis

Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for differentiated...

Is One Type of Water Healthier Than Another? Here’s What Experts Say

SUNDAY, July 6, 2025 — Alkaline. Electrolyte. Flavored. Walk down the beverage aisle and you’ll find all kinds of waters promising extra health...

Read more news...

Recently Added

Recently added consumer and prescribing information: Lynozyfic, Arynta, Harliku, Ibtrozi, Miudella, Opdivo Qvantig, Alyftrek, Crenessity, Ensacove, Steqeyma

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Ekterly Ekterly (sebetralstat) is an oral plasma kallikrein inhibitor for the on-demand treatment of hereditary angioedema attacks in adults and...
  • Lynozyfic Lynozyfic (linvoseltamab-gcpt) is a bispecific B-cell maturation antigen (BCMA)‑directed CD3 T-cell engager for the treatment of relapsed o...
  • Zegfrovy Zegfrovy (sunvozertinib) is an irreversible EGFR inhibitor for the treatment of locally advanced or metastatic non-small cell lung cancer...

More FDA approvals